Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Good article, dense with information! So what?
If there are no takers on the products, all the print in the world doesn't make a difference.
Yes! At the cost of $67.50. BIG SPENDER!!! Risky...lol
...with investor funds...
Yup! Same website with no news. Meaningless.
The patent wasn't BS. The rest, I don't know...
Yup!
Agreed. This is dead in the water and I do not believe it will be resurrected. LF could have provide some insights, but he's not lifted a finger to do that, indicating there's nothing to report. I have wondered if the technology he offers is too sophisticated for the users. How much training is required? How much time investment is required in terms of the learning curve? Who has the time? And, as hospitals and Dr.'s offices have already invested in medical software programs, the hard sell is convincing them to abandon what they've already invested in, reinvest in and learn a new and complicated system, and be certain their staff builds expertise.
Who is willing to do that, in spite of the potential?
FYI - Website is STILL down. Been a month or so, hasn't it? Telling, don't you think?
lol - This was broken a long time ago and it won't be fixed. Notice I said "it won't be fixed" instead of, "it can't be fixed".
Yes. This penny hiccups every now and then and we get a bounce. It also farts, in which case we dip.
I second that motion.
Hi Miketrav69! I agree there may be other reasons Weber sees jail time sooner or later. But running this corporation into the ground is not one of them.
He could resurface with another venture and there will be suckers to fall into his grasp all over again. But I think he'd be an absolute moron to try because I think any efforts to try another venture will be heavily scrutinized by the SEC. But hey, life-long criminals are exactly that and they ALWAYS think there is another play to do and always think they can get away with it, just one more time. Weber's no different.
Eventually, they will get him, but not for BBDA.
Miketrave69 - You and I go way back on this board. But I totally disagree with your analysis that Weber will see jail time. I said it before and I'll say it again: Brian Weber, past CEO of Bebida Beverage will not see one day of jail time due to his activity as CEO of the now defunct corporation. We all agree he SHOULD see jail time. But he won't.
Did he have a real product? Yes! Did he make efforts to jump-start it? Yes! Did he pump it with potential opportunities that never materialized? Yes! So what? That happens all of the time with corporations big and small.
To prove his pumps were totally false, that he never INTENDED to deliver, never INTENDED to hook up with those of celebrity status, never INTENDED to push his cool-aid overseas, never INTENDED to bag big whales - to prove all of that isn't possible. In fact, all of his ACTIONS say he did try to do those things, albeit in his own, slimy, hillbilly, half-assed style.
If I'm wrong - ok then - I'll publicly admit I was wrong. But I have seen many, slimier creatures than Weber get away with investor money. His MO is no different than many other scoundrels who walk away with millions of investor dollars, relatively unscaved.
Is the SEC aware of Weber? Yes! Are they paying attention to him and what he's done? Likely! But if they had the goods on him, he'd be facing charges already. Is he facing charges? No!
It is too bad, but Weber will get away with it - this time. You can be certain he's already giving consideration to, and is likely involved in another start-up. He'd be stupid to run the same game that he's just exited. That will do him in, for sure.
My opinion is that LF knew when the plane stopped flying. He is not unlike any other in terms of divulging bad news so as to maximize his profit and minimize his losses. Still, this past year's game playing with the well-designed website was, also in my opinion, misleading. Was that intentional? Only he knows the answer to that.
Yes. There hasn't been any official filings for years. That should be the first clue, but oftentimes startups don't keep up with filings since in pink land they are not required to. This seemed promising and worth the risks. For me, the lesson learned is, if there are not legitimate filings, steer clear.
If you look at a few of my pasts posts, I called him out of the business location and a few other things related to his "activity". Possibly, the yanking of the website is his acknowledgement that this is no longer a going concern.
Well, we know no one is buying shares. But do you know for sure that is their reasoning? Or are you taking an educated guess?
Yup! Maintenance? Updates? A decision to pull the plug?
How many years has that been the mantra?
Agreed!
Expecting a change in this for 2016?
Merry Christmas anyway!
Definition of a weasel:
wea·sel
'wez?l/Submit
noun
1. a small, slender, carnivorous mammal related to, but generally smaller than, the stoat.
2. informal, a deceitful or treacherous person. synonyms: scoundrel, wretch, rogue; More
verb
1. achieve something by use of cunning or deceit.
"she suspects me of trying to weasel my way into his affections"
Give me a proper noun that sounds like weasel.
Uh huh...The definition works.
Good call, StrikeWilliams! That has often been the case.
Perhaps Landon's primary interest (EMI) prevents valuable activity from occurring in his side job. The below information is very old news, but I tihnk it impacts QUTURE in a myriad of ways.
SOURCE:EraStar, Inc.
8/1/2014 12:19:59 PM
EraStar, Inc.
EraStar Medical, Inc. Appoints Landon Feazell as Chief Innovations Officer
LAS VEGAS, NV, United States, via ETELIGIS INC., 08/01/2014 - - EraStar Medical, Inc., (EMI) a subsidiary of EraStar, Inc., is pleased to announce that Landon Feazell has joined EMI as a Founder and Chief Innovations Officer.
Landon Feazell is recognized for his leadership, innovation, and expertise in clinical performance and outcomes measurement. He is also responsible for developing technology on the best strategic technology platform for healthcare analytics and big data. His innovative systems have transformed manual processes through information technology with extensive, optimal evidence-based clinical content to translate data into clinical knowledge solutions. Mr. Feazell’s extensive publications in 2003 are considered sentinel in the “quality-value proposition,” signaling value-driven changes in healthcare delivery and payment models for all constituents in the digital transformation of health and health care.
"I am honored to join the dynamic, talented and diverse EMI team,” said Mr. Feazell. “Their announced intention to merge with Cytta Corp (OTCQB-CYCA) will provide the connectivity tools essential to implement dramatic changes in healthcare delivery and payment models. Combined with the technology of EMI’s breakthrough license acquired from Quture, Inc., the common data platform and analytics tools for providers, engaged patients and payers will collectively drive significant revenues to EMI / Cytta.
By capturing real-time patient data with Cytta’s remote monitoring systems integrated into the EraStar license for the Quture strategic data platform, physicians and patients across the globe are empowered with point-of-care health and wellness information. This connectivity and analytics platform provides predictive and intelligent clinical knowledge across the spectrum of individualized health and wellness care. For physicians, payers and patients, it is the technology necessary for value-based payment systems.
Mr. Feazell further stated, “Having worked in healthcare quality, proactive patient safety, and the transition to electronic medical records and engineering data aggregation from disparate databases for analytics and clinical knowledge solutions throughout my professional career, it was easy to recognize the synergies between EMI and my other corporate endeavors. I am excited to accept the challenges to be EMI’s Chief Innovations Officer.”
For over 40 years, Mr. Feazell’s companies have developed and implemented clinical knowledge solutions in hundreds of hospitals and systems, HMO’s, physician groups and practices, for governmental agencies, and insurance companies. His extensive knowledge of the health and healthcare market, his strategic alliances and professional relationships, as well as his expertise in transforming data to clinical knowledge solutions are among the valuable assets he brings to EMI.
Mr. Feazell’s undergraduate degree is from Duke University, and his graduate studies in medical sciences was at the University of West Virginia Medical Center and then law at the University of Denver, College of Law, where he served as Chairman of the National Conference of Law Reviews. Mr. Feazell will continue in his leadership positions with Quture International, Inc. and Quture, Inc. The synergies with the common data platform and corporate strategies will benefit EMI and Quture exponentially.
Vanessa Luna, EraStar, Inc. COO stated, “Mr. Feazell’s accomplishments and experience are central to the vision and business strategies of EMI. As Chief Innovations Officer, he will lead the combined efforts of Cytta’s tools, pending merger, with his technology solutions and analytics platform. We look forward to collaboration with Mr. Feazell, as EMI becomes an incubator for health and healthcare products through integration of knowledge from big data into the emerging digital health market. His insight and leadership strategically positions EMI to become a leading force in the rapidly changing health and healthcare markets. His technology solutions for will prove instrumental to our continued success.”
As previously announced on Wednesday July 9, 2014 Cytta Corp. (OTCQB:CYCA) announced that it has entered into a Letter of Intent with EraStar, Inc., a Las Vegas based marketing business, to merge the two Companies. (http://www.marketwired.com/press-release/cytta-enters-into-letter-of-intent-to-merge-with-erastar-inc-otcqb-cyca-1928036.htm)
About EraStar, Inc.
EraStar, Inc. is a dynamic Las Vegas based marketing business that offers the following services: Comprehensive Marketing Strategies for Public and Private Institutions, Public Relations and Media Activities, Product Marketing, Support Services, Business Development Consulting, and Lead Generation. EraStar currently provides services to variety of clients in a number of industries nationwide.
About EraStar Medical, Inc.
EraStar Medical Inc. (EMI) is a sub division; Nevada Corporation of EraStar Inc. a dynamic Las Vegas based marketing business. EraStar Medical Inc. creates a structure within its parent company that allows management to apply their advisory services and med-tech acquisitions specifically in the booming med-tech sector. EMI’s connectivity and analytics platform provides predictive and intelligent clinical knowledge across the spectrum of individualized health and wellness care. EraStar Medical seeks to provide cost efficient technical strategies that will create superior healthcare outcomes for physicians and patients globally.
My guess, and it is PURELY a GUESS, is that it was Landon trying to keep peeps on board. The pps went up a tiny bit and look at the excitement and chatter. I think (again just an opinion) he does this on occasion just to peek curiosity and keep us projecting that something is on the move. It's just a ploy, imo. And it works to a degree.
On the other hand, some actual news will be a welcome sight. Again, and imo, there's no news coming now or in the near future. I believe there is no longer any interest. Why?
I wonder if the product is a little too sophisticated and ahead of its time. How much training would it take to operate the system to it's max potential? What will the costs be to migrate from presently operated systems to Quture's? Is it a more expensive system than what hospitals and doc's in general currently use? And is it too complicated for users to assimilate all functions? Do they have the time and desire to understand all functions, regardless of the capacity to revolutionize medical care?
I've thought about those questions and I don't know the answers. But if there's hesitation for potential consumers, I'll bet my questions are likely theirs. Again, imo.
You know it's not that simple. If this get's pumped to a level anywhere close to when I got in .003 - .004, you can be certain I'll get out because at that point, I'll recoup my losses. So even at .001 or .002, I can get a larger portion of my investment back. But at the present level of .0005, there's a glimmer of hope that a pump will get the pps to a point whereby my losses are not as great.
But you already know this. So why the stupid-ass remark?
Fido is correct! The product's worth has been tested. The results are exactly what we see. No interest.
End of story...
Agreed. This is dead.
I'm resigned to believe I've lost all I have invested. I could try to sell, but am not willing to take a hit like that. So, I am held hostage with little hope I'll even get back half of what I have out into this.
No news, no movement, no interest. DOA!
Actually, I build websites for folks as a side job and I can tell you that our website is actually quite sophisticated. He spent a pretty penny for it, of that I am certain. However, way to many of the drop down menus are still empty of material and they've been that way since the website went live.
Doesn't matter. Having a website means nothing in terms of a companies strength and I think that's what you're getting at. I wholeheartedly agree.
I am not able to say that we've been had. I DO think it is safe to say the plans and attempts to grow this into a viable commodity have failed. I don't think there is any interest. If there were, we'd be flying by now.
I do think it is incumbent on the CEO to tell us that, if in fact this is a dead play. The fact that he doesn't come forth with that announcement or any other news for investors (beyond his meaningless tweets) is quite telling and creates deep suspicion regarding this company's future.
Another week, no glitz, no glamour, no pumps. no dumps, no nothing. I can do without the glitz, glamour, pumps, and dumps. You've got to give us something. Or is it that you have nothing to give?
You know what, LF? If doc's and hospitals are given you the BIG BLOWOFF, then tell us that. None of us are throwing any more money away on this anyway. We will be able to walk away, move on, and forget about this.
It's been several years and this baby is DOA imo. It was aborted in mid gestation. No one wants the product, right?
Tell the truth!
Oy vey...
I think we can safely say the longer this sits idle, the more likely it won't go anywhere. It'll take more than tweets and Landon's Notes to gain investors. At this time, Landon's Notes are really all we have.
I admit that Landon's notes are informative, intelligently and scientifically written, and very promising in terms of potential. Still, that is all we have and we have no real knowledge that he has or is moving forward and contracting with any hospitals, doctors, and/or health insurance companies.
I have a friend that's a doc who also does rounds in a Burlington, Vermont hospital. He runs his own practice and it is large enough that it requires software to keep track of his patients and do his billing. He is approached by vendors all of the time, as most doctors are, who try to get him to use their product.
He's NEVER heard of QUTURE. I shared literature with him; he is fascinated by the product's potential.
The below link is to an article that is worth a read and of interest to investors.
Landon's Notes
inforthemoney2 -
If he wants to tweet - how about validating the corporate address.
Is the QUTURE International address still:
200 Magnolia Ave, Daytona Beach, FL 32114?
If so, when googled and with a street view, that address shows Buckmaster Law and a few other businesses.
Seems Buckmaster law occupies that entire section of the building and occupying QUTURE's address at 200 Magnolia Avenue, and there are other businesses in other sections of the building as well. I did a 360 (as much as was possible) around the building. There are NO signs or other indicators that QUTURE is located in that complex.
Anyone ever visit headquarters? Anyone here testify the business actually has a brick and mortar location?
Landon - If QUTURE is no longer at that address, what about being straight up with us. How about Tweeting the new address, if there is one?
Shorts!? Guess that explains the tremendous average daily volume numbers. lol
I believe you are both correct, unfortunately. Penny's are soooo freakin risky. Even with plays that look promising. His website is one of the best I've seen in a long time; clearly there was some good money spent on it's development. One would think that with such a great website, this has to be a seriously good play, right? Wrong!!!
It is unfortunate that we have nothing to go on except that there is no news, no filings, no movement of any kind that we are being made aware of. There may be things happening behind the scenes but we have no way of knowing since LF sees no reason to keep us updated. Since he doesn't keep us updated, he either has no value for his investors or no news to report. More than likely, both are true.